Transcript Highlights:

• in medically complex children.
• in medically complex children.
• in medically complex children.
• This medication has only been on the market since 2019.
• Too often, it resembles medical kidnapping rather than medical care or parental partnership.

Bills: S0042, S0578, S0624, S7018

Keywords: child protection, medical records, investigation, abuse, neglect, healthcare, Child Protection Team, diagnosis, Alzheimer's disease, Alzheimers, dementia, related dementias, brain health, early detection, caregiver support, elderly affairs, Department of Elderly Affairs, Department of Health, public health outreach, memory loss

Summary: The committee met with a quorum and first heard SB 624, which would codify DCF’s current practice of allowing batterers intervention programs to offer supplemental faith-based activities so long as participation is voluntary. The bill drew support from faith-based and family organizations, which argued it would restore access to effective rehabilitation options and remove discriminatory barriers. SB 624 was reported favorably after a roll call vote. The committee then heard SB 42, which would require child protective investigators and child protection teams to rely on qualified medical professionals when a child has a documented pre-existing diagnosis or when a parent requests an exam, and would require clearer notice to parents and custodians at the start of an investigation. Testimony overwhelmingly came from parents, advocates, and disability rights representatives describing cases in which medically complex children were allegedly misdiagnosed as abuse victims and families were separated unnecessarily. Members expressed sympathy and support, and SB 42 was reported favorably. Next, the committee considered CS/SB 578, creating an Alzheimer’s disease awareness initiative within the Department of Elder Affairs to promote early detection, brain health education, research updates, and clinical trial awareness, with outreach focused on older adults and at-risk populations. An amendment was adopted to place the campaign within the Alzheimer’s Disease Initiative. A caregiver testified about the need for public education and early diagnosis, and the bill was reported favorably. The committee also took up SPB 7018, a committee bill on child welfare that would extend the definition of “visitor” for foster homes to reduce repeated background checks, make the Step Into Success foster youth workforce pilot permanent and statewide, and create a program through the Florida Institute for Child Welfare to catalog best practices among community-based care lead agencies. The bill was approved as a committee bill and reported favorably. Finally, the Department of Children and Families presented its 2025-26 final funding methodology and rates report for community-based care. Members questioned the proposed tiered model, including insurance costs, risk corridors, prevention funding, performance measures, and regional funding disparities. No vote was taken on the presentation, but members discussed the possible need for follow-up legislation and additional stakeholder input.

Transcript Highlights:

• Our medical malpractice claims are being progressively squeezed out of the medical malpractice system
• But medical costs are outside the cap.
• For medical malpractice premiums, it's from the Medical Liability Monitor, and they only have selected
• With the medical community by a 49% investment, by maintaining medical provider control of the facility
• That a licensed medical provider own the controlling stake or a group of licensed medical providers on

Transcript Highlights:

• , medically accurate.
• , medically accurate.
• That's not the issue, because we all believe that most medical or all medical interventions do their
• I mentioned that to draw a comparison as to a medical treatment, a medical intervention, is just that
• Senator Luna, one other consideration you were asking about with medical intervention: receiving a medical

Summary: The Senate Committee on Health and Welfare met on May 13 and approved the minutes from the prior week before taking up a series of House bills, many of them with testimony from sponsors, agency officials, and stakeholders. Early action included HB 971, which would direct LDH to equalize Medicaid reimbursement rates between independent rural health clinics and hospital-owned rural health clinics; the sponsor described a significant payment disparity and the committee reported the bill favorably. The committee also deferred HB 1030 and HB 796 until the following week before moving to other items on the agenda. Several bills dealing with Medicaid and provider regulation were advanced. HB 414, as amended, closes a loophole so health care providers cannot hire unlicensed workers with certain serious out-of-state convictions; amendments addressed effective dates, FBI background-check issues for therapeutic group homes, and delays for direct support professional applicants caused by minor record issues. HB 740, as amended, creates an independent review process for Medicaid claims disputes in the coordinated system of care for behavioral health providers, with amendments clarifying applicability dates and program definitions. HB 786, which prohibits extrapolation in managed care claims recoupments and requires recovery to be based on actual overpayments or underpayments, was also reported favorably. HB 915 set timelines and accountability standards for prior authorization and utilization management in Medicaid managed care and was reported favorably after testimony about delays in care. The committee also heard and passed several bills affecting health professions and facilities. HB 405 simply updates the name of the national acupuncture certification body. HB 1095 allows nursing homes to use alternative power sources while keeping existing generator and fuel requirements. HB 557 defines long-term care pharmacies for policy purposes. HB 779 authorizes expedited partner therapy prescriptions for certain sexually transmitted diseases. HB 933 creates an optional commemorative birth certificate, with part of the fee going to the Office of Women’s Health. HB 796, carried by another representative for the author, establishes a chiropractic preceptorship program with on-site supervision requirements and was reported favorably after questions about student training and patient safety. The committee also heard emotionally charged testimony on HB 288, which would place the term “miscarriage” alongside “spontaneous abortion” in medical documentation and patient communication. Several witnesses described the distress caused by current coding language, and supporters said the change would make records more compassionate and understandable; the bill was reported favorably. HB 403 increased the cottage food gross-sales cap, and after testimony from small producers and the committee’s discussion of other states’ higher limits, an amendment raised the cap to $150,000 before the bill was reported favorably. HB 930 modernizes cosmetic-product regulation and creates a small home-based producer exemption under a wholesale-sales threshold; it was also reported favorably. Finally, HB 1041, a no-mandate bill restricting discrimination based on medical intervention status, prompted extended debate over exemptions for schools, hospitals, and other entities, with one amendment failing on a roll-call vote and the discussion continuing over the scope of the bill and federal funding concerns.

Transcript Highlights:

• Oliverson: The purpose of this bill is to make this particular medication, which is a medication Dr.
• Oliverson: A prescription-only medication, yes sir.
• Medications have specific treatments. Medications can treat specific diseases.
• It has serious interactions with other medications.
• No credible medical authority supports this bill.

Bills: HB25, HB48, HB149, HB254, HB26, HB192

Keywords: ivermectin, pharmacist authority, prescription-free, healthcare regulation, patient access, HB 48, Texas alert notification systems, emergency alerts, public warning systems, alert fatigue, notification fatigue, Texas Division of Emergency Management, Department of Public Safety, DPS alerts, emergency management, State of Texas Emergency Assistance Registry, STEAR, disaster notifications, weather alerts, Amber Alert

Transcript Highlights:

• Are these like medical schools, or are they companies?
• People are very set in kind of how they think of medical and how they think of medical, and I feel like
• We tried the medication. We tried the medications, and that's when the suicidal ideation began.
• She needed a medical workup. She needed someone to ask why.
• There were multiple psychiatric and medical inpatient days.

Keywords: 995, all

Summary: The Joint Committee on Mental Health, Substance Use and Recovery opened its first public hearing of the 2025–26 session with remarks from the Senate and House chairs outlining the committee’s priorities. They noted recent work on addiction and recovery legislation, the ongoing youth behavioral health crisis, and that members might need to leave periodically for floor votes. The chairs explained hearing procedures, including three-minute testimony limits, written testimony deadlines, and reporting deadlines for Senate and House bills. The hearing then focused on several bills related to youth mental health, overdose prevention, and psychedelic treatment research. A major portion of the hearing centered on bills to improve youth crisis response and overdose prevention. Testimony strongly supported bills to print the 988 Suicide and Crisis Lifeline on student ID cards, with speakers from mental health organizations, crisis centers, and individuals sharing personal stories of depression, suicide attempts, and the importance of making 988 as familiar as 911. Another set of bills would require schools to stock naloxone and provide overdose prevention education. Physicians, harm reduction advocates, students, and grieving family members testified that school-based Narcan access and education could save lives, reduce stigma, and help students recognize overdoses and understand Good Samaritan protections. Senator O’Connor and Tamika Perry also testified for a bill to strengthen substance use prevention education and reduce overdose abandonment, emphasizing the need to teach students about overdose risks and the legal protections for calling 911. The committee also heard testimony on a bill to authorize a pilot program for psychedelic treatment in licensed facilities. Senator Friedman and several medical and behavioral health professionals argued the proposal was a narrow, research-based approach distinct from the broader ballot question rejected in 2024. They said the bill would allow only a small number of supervised clinics to use psychedelics for conditions such as depression, PTSD, anxiety, and substance use disorders, with data reporting and Department of Public Health oversight. Supporters described it as a cautious way to study promising treatments while avoiding unsupervised or commercialized use. Finally, the committee heard support for a bill to create a special commission and five-year strategic plan for children’s behavioral health services, with testimony that the current system is fragmented, difficult for families to navigate, and strained by workforce and funding challenges. No votes or final actions were taken during the hearing; the committee primarily received testimony and questions on the bills.

Transcript Highlights:

• And medical debt is not like other debt.
• debt of medical debt.
• You know medical debt of medical debt.
• And medical debt is Minnesota as well.
• Is there other medical providers.

Keywords: 1187, senate, all

Transcript Highlights:

• <00:12:43.959> school discounted housing medical school discounted housing medical school
• that utilize a team of Medical that utilize a team of Medical Specialists<00:19:27.679> to
• <00:19:40.080> schools have again for the medical schools have again for the medical schools
• additional Medical additional Medical students<00:38:28.800> that<00:38:29.800> uh
• on dementia when they were in medical on dementia when they were in medical school<00:43:15.960>

Keywords: 912, senate, all

Summary: The Committee on Higher Education met on February 6 and began with decision-making items. SB 663, concerning additional positions for the University of Hawaiʻi College of Tropical Agriculture and Human Resources, was deferred again after the chair said the university’s response did not include the requested details on vacant positions, recruitment status, and fill dates. The chair said the committee needed the full information before considering new positions, and the university apologized for treating the request as informal rather than a formal committee inquiry. The committee then discussed SB 672, relating to capital improvement projects for the Y. Manalo Research Station. University representatives said the project had been identified late because of timing and that they were still developing a broader plan for SEAR research facilities. The chair questioned how the project fit within the university’s existing Board of Regents-approved CIP priorities and whether any current priorities should be displaced. The university said it could not unilaterally reprioritize the budget, and the measure was deferred pending better direction on how it fits into the overall plan. For SB 557, which would require the John A. Burns School of Medicine to direct a study on physician and dentist recruitment and retention for Maui, the committee heard strong testimony in support from Maui health care providers and community representatives. Supporters described severe shortages of physicians and dentists, long waits for care, and the need for housing, loan repayment, scholarships, transportation, and telehealth support to retain providers. The university said it was willing to help and suggested the work could be done through existing rural health and AHEC efforts. The bill was kept alive for further work, with the chair encouraging the parties to develop a plan. The committee also heard SB 1107, establishing a medical education position at JABSOM to support ECHO-style mentorship and guidance programs. The university opposed the bill, saying it did not believe the measure addressed a problem that needed fixing and that Hawaiʻi already has five ECHO clinics administered through the Hawaiʻi State Rural Health Association, not JABSOM. The committee then took up SB 1204, concerning integration of the Kakaʻako medical school and cancer center. University leadership asked for time to develop a plan and timeline, possibly with an external consultant, and requested the bill be withdrawn. The chair expressed skepticism, citing long-standing concerns about the cancer center’s finances and planning. Testimony included support from the American Cancer Society and a patient who warned that integration could jeopardize the cancer center’s NCI designation and clinical trials, while a university vice president said the NIH P30 grant does not require the cancer center and medical school to remain separate and that many NCI centers are integrated. No final votes were taken on the measures discussed in the excerpt.

Transcript Highlights:

• <00:25:55.120> cannabis of Health in the the medical cannabis of Health in the the medical
• states that sort of created medical states that sort of created medical programs<00:26:01.320>
• He said even a small retailer could offer medical products to medical patients.
• products to medical patients.
• we have a tiny medical market.

Keywords: 1183, house

Summary: The Minnesota House Commerce Committee held its inaugural meeting with Chair Tim O’Driscoll and co-chair Representative Greg Davids opening the session and inviting members to introduce themselves. Members briefly described their districts, business backgrounds, and priorities, with recurring themes including small business competitiveness, insurance and health care access, property and real estate issues, agriculture, and making Minnesota easier to do business in. Committee staff also introduced themselves and reminded members and testifiers about sign-in procedures and microphone use. The committee then heard an overview from Eric Toell, interim director of the Office of Cannabis Management, on the agency’s work and budget priorities. He said the office now oversees adult-use cannabis, medical cannabis, and hemp-derived cannabinoid products, has grown from about nine employees to 90 full-time staff plus temporary workers, and has been working with a Cannabis Advisory Council on testing, warning labels, and implementation issues. He also described outreach efforts, including webinars, newsletters, guidebooks for local governments, and office hours for applicants, along with enforcement of hemp-derived product rules through more than 3,000 inspections and an increase in compliance rates from about 35% to 75%. Toell also reported that the medical cannabis program has surpassed 51,000 patients and nearly 2,500 registered health care providers, and that a chronic pain report found more than a third of patients reported decreased pain. On the adult-use side, he said the office has posted proposed rules for public comment, plans to adopt them after review, and will open a licensing window from February 18 to March 14. He explained that the office is also managing community reinvestment grants and a technical assistance grant, with an emphasis on safeguards to ensure funds reach intended recipients. No votes were taken during this meeting.

Transcript Highlights:

• He was started on oral medication to treat his symptoms.
• insurance company covered the medication insurance company covered the medication and<00:09:48.519
• that can be helpful we have a medication that can be helpful this<00:10:47.040> medication<00
• Answer: I think we said $26,500 for one of the medications a year.
• period know that there is a medication period know that there is a medication that<00:14:06.120>

Keywords: 1187, senate, all

Transcript Highlights:

• likely to have access to medical care. likely to have access to medical care.
• They receive medications within office. They receive medications within our<01:29:41.360> office.
• <01:30:42.239> of<01:30:42.400> medication based on the type of medication based on
• providing comprehensive medication providing comprehensive medication treatment<01:30:55.520>
• As you've and medication treatment.

Keywords: Meeting Start: 00:00:00 Roll Call: 00:00:05 25 RS HB 534 - AN ACT relating to actions for forcible entry and detainer: 00:01:45 25 RS SB 111 - AN ACT relating to juvenile justice: 00:23:46 Children's Advocacy Centers of Kentucky: 01:13:26 Opioid Use Disorder (OUD) Treatment in State and County Correctional Facilities: 01:25:28, 958, all

Summary: The committee approved the September 18 minutes and then heard testimony on House Bill 534, which would automatically seal dismissed eviction filings and protect youth from public disclosure in forcible detainer cases. Rep. Susan Tyler Whitten and George Ecklan of the Coalition for the Homeless said the bill is aimed at reducing housing barriers for Kentuckians, especially those with dismissed cases, while preserving landlords’ rights to pursue rent, collections, damages, and other legal remedies. They said the proposal was developed with input from landlords, clerks, judges, AOC, and service providers, and noted that similar laws exist in other states. Several members, including Sen. Neimes, Rep. Deetsz, Rep. Cole Carney, and Sen. Thomas, expressed support while emphasizing that the bill is narrowly tailored to dismissed cases and should not affect legitimate landlord claims; Sen. Wheeler raised concerns about cases involving settlements or delays and whether future landlords should know about them. The sponsors responded that the bill only covers dismissed actions, that dismissals require a judge’s order, and that the goal is to remove barriers created by records that remain publicly visible even when a case is resolved. The committee then took up Senate Bill 111 on juvenile justice. Commissioner Randy White, Kentucky Hospital Association President Nancy Galvanny, and Dr. Clark Lester of the University of Kentucky said the bill would require a secure state-run facility for youth with high-acuity mental health needs in detention and, until that is built, create a process with incentives for private hospitals to provide inpatient treatment with safeguards and increased compensation. They argued that detention is not an appropriate setting for severely mentally ill, violent youth and that private psychiatric hospitals often refuse these referrals or discharge them early. Dr. Lester cited recent referral data showing high denial rates for juvenile justice youth in private hospitals in August and September, often due to aggression, and described a case in which repeated placement attempts failed because of violent and self-harming behavior. The presenters said the bill is intended to fill a service gap and improve safety and outcomes for youth, staff, and hospitals, but no vote or final action on the bill was taken in the portion of the meeting provided.

Transcript Highlights:

• So, we'll go from three medical schools to four.
• So, we'll go from three medical schools to four.
• So, we'll go from three medical schools to four.
• So, we'll go from three medical schools to four.
• qualified medical health health care. qualified medical health health care.

Keywords: 00:00 - Call to Order/Roll Call 01:17 - Discussion of 26RS SB 137 07:15 - Roll Call Vote on 26RS SB 137 09:42 - Discussion of 26RS SB 147 10:48 - Roll Call Vote on 26RS SB 147 11:56 - Discussion of 26RS SB 56 13:48 - Roll Call Vote on 26RS SB 56 14:43 - Discussion of 26RS SB 116 20:17 - Roll Call Vote on 26RS SB 116 21:23 - Adjournment, 958, all

Transcript Highlights:

• [Snorts] The medications we are talking about today, puberty-suppressing medications and hormones, are
• We at Gender Justice believe that gender-affirming medical care is mainstream medical care.
• care is mainstream affirming medical care is mainstream medical<00:13:50.320> care.
• It should remain in medical care.
• c> or that have medic like provide medic or that have medic like provide medic or get<00:29:33.279

Keywords: 919, house, all

Summary: State lawmakers, the attorney general, advocates, and parents held a press event responding to Children’s Minnesota’s announcement that it would pause some gender-affirming care for minors. Speakers, including Rep. Lee Finke, Hannah Edwards of Transforming Families Minnesota, and Jess Braverman of Gender Justice, said the pause was driven by federal pressure and threats from the Trump administration and HHS, not by medical best practice. They emphasized that gender-affirming care remains legal in Minnesota under the state’s Human Rights Act, Trans Refuge law, and insurance protections, and argued that interrupting care harms trans youth and families, especially those who moved to Minnesota for protection. Testimony focused on the emotional and practical impact on families: loss of trust in providers, delays in treatment, travel and intake wait times, and the stress of having to scramble for continuity of care. Speakers described the care as evidence-based, medically necessary, and life-saving, and said the federal government was using coercion and misinformation to intimidate hospitals and doctors. The attorney general said his office and coalition partners are litigating related federal threats, including a separate RFK Jr. declaration and proposed federal rules, and that Minnesota officials are working to preserve access and enforce state protections. In response to questions, speakers said the state’s legal tools are strong but limited against federal action, so they are relying on court challenges and enforcement of existing state law. They said Children’s Minnesota had been specifically targeted by federal officials and that the hospital’s pause was tied to that pressure. No votes were taken; the event ended with a call for continued public and institutional support for trans youth and for Children’s to resume care as soon as possible.

Transcript Highlights:

• You want people who have a medical background to make this medical determination, correct?
• We're not a medical facility.
• and medical professionals, of Medical Examiners, Louisiana Board of Pharmacy, hospitals and medical
• It is a legal record, but it’s also part of the medical record and becomes part of the medical record
• the best medical care.

Summary: The committee heard a personal privilege update on HB 1227, which Representative DeWitt said would return next week as a proposed HCR for a two-year study of the three-doctor panel after discussions with Dr. Nia Colotta. Better Louisiana also presented its new Leadership Louisiana Health Fellows Program, describing it as a data-driven leadership initiative focused on health care workforce, rural access, chronic disease, and other system issues; members discussed whether the program could also help generate policy research, including on managed care organizations. The committee then considered SB 427 on anatomical gifts. After adopting technical amendments, Senator Presley and Dr. Jeff White explained that the bill would strengthen organ donation law by creating a decision registry that records both yes and no choices, clarifying the legal effect of refusal, and codifying ethical principles such as the dead donor rule. Questions focused on organ viability, registry procedures, minors, and a Monroe case involving a disputed donor designation. Supporters included LOPA and the Louisiana Conference of Catholic Bishops, and the bill was reported favorably. HB 946, dealing with hospital price transparency and compliance with federal pricing rules, drew extensive testimony. Representative Landry and a witness from Patient Rights Advocate described it as a consumer transparency measure, but the Louisiana Hospital Association opposed the bill’s state-level enforcement and debt-collection provisions. Landry offered an amendment removing the debt-collection and affirmative-defense language, but after debate the substitute failed on a 5-6 vote and the bill was voluntarily deferred. The committee also reported favorably on SB 109, which revises membership qualifications for the Louisiana Emergency Medical Services Commission; SCR 20, urging federal flexibility on Medicaid redetermination for elderly and disabled beneficiaries; SB 216, allowing coroners to rely on licensed practical nurses for medical pronouncements of death; and SB 45, exempting certain gratuitous hospice houses from licensure, with testimony from hospice house operators and supporters. Finally, HCR 71 by Representative Chasson sought an LDH study of how Louisiana’s law and guidance on pregnancy-related emergency medications is working in hospitals, urgent care, and retail settings. Supporters said providers are hesitant to use medications such as misoprostol because of stigma and uncertainty, while opponents from Louisiana Right to Life argued the resolution was unnecessary and could create controversy. The discussion centered on whether the study should be narrowed or made more objective, but no final action on the resolution was reached in the portion provided.

Transcript Highlights:

• I went to medical school in Nigeria, so I was very comfortable with antimalarial medications.
• director of the Texas Medical Board.
• The medication, they were for inadequate medical records, inadequate history, inadequate consent, things
• ; you wouldn't list the medication.
• to policy put out by the American Medical Association and the American Board of Medical Specialties.

Bills: SB331, SB883, SB926, SB1137, SB1138, SB1144, SB1151, SB1236, SB1270, SB1522, SB1869, SB2207, SB2422

Keywords: healthcare, cost disclosure, transparency, administrative penalties, health facility compliance, COVID-19, off-label use, prescription drugs, patient access, medical standards, insurance, physician ranking, incentives, fiduciary duty, health plan issuers, SB 1137, group home, assisted living, residential care, board and care

Transcript Highlights:

• Over 50% of patients with medical illnesses of all kinds don't take their medications as prescribed,
• I was put on medication and psychotic medication, and I felt like my heart was dead.
• I was medical director.
• She didn't abuse the medication. She took less. But unfortunately, the medication took her life.
• medication, anxiety medication, as well as blood pressure medication.

Keywords: 995, all

Summary: The Joint Committee on the Judiciary held a lengthy hearing on several juvenile justice and parole-related bills, with much of the testimony focused on H. 2051/S. 1087 to end lifetime parole for juveniles and emerging adults, and H. 1923 to raise the age of juvenile court jurisdiction to include 18-, 19-, and 20-year-olds. Chairs Brandy Fluker-Reid and Lydia Edwards opened the hearing by noting the large number of bills and witnesses, the need to keep testimony moving, and special procedures for incarcerated witnesses and sensitive testimony. They also acknowledged the historic nature of the hearing being chaired by two Black women attorneys. No votes were taken during the hearing itself. Many incarcerated speakers and advocates supported ending lifetime parole, arguing that young people can change, that lifetime supervision creates constant fear of technical violations, and that it undermines rehabilitation, family stability, employment, and reintegration. Several testified about their own trauma, youth, and growth in prison programs, while others emphasized the costs of decades of supervision and the racial disparities in the system. Support also came from elected officials, UTEC, the Transformational Prison Project, United Way, CPCS’s Youth Advocacy Division, the Massachusetts Coalition to Prevent Gun Violence, and others, who said juvenile systems are better suited to developmentally appropriate treatment and that the bills would improve public safety and reduce recidivism. There was also opposition, including testimony from family members of a murder victim who argued that lifetime parole should remain for serious violent crimes and that some offenders are not sufficiently rehabilitated. One virtual witness described a family tragedy involving the kidnapping and murder of her infant nephew and warned that ending lifetime parole could remove needed long-term supervision for dangerous offenders. In addition to the juvenile justice bills, the committee heard testimony on H. 1867, a bill related to continuing care for severe mental illness, and H. 2063, which would increase penalties for assaults on correction officers and other prison staff; the correction officers’ union supported H. 2063 and related safety bills. The hearing continued with many more witnesses and bill topics, but no final committee action was announced in the portion provided.

Transcript Highlights:

• We've had great help from our medical communities.
• We've had great help from our medical We've had great help from our medical communities.<00:03:16.800
• And medical debt is not like other debt.
• Um Senator, we can't talk about medical Um Senator, we can't talk about medical debt<00:18:51.200
• Is there other medical providers.

Keywords: 1187, senate, all

Transcript Highlights:

• You want people who have a medical background to make this medical determination, correct?
• We're not a medical facility.
• and medical professionals, Of Medical Examiners, Louisiana Board of Pharmacy, hospitals and medical
• In-house medical team, attending physicians, and medical providers who make rounds, code teams ready
• the best medical care.

Bills: SB57, SB405, HB62, HB193, HB203, HB222, HB246, HB420, HB475, HB486, HB574, HB584, HB815, HB949, HB1092, HB1214

Keywords: SB 57, Act 735, Act 463, nutrition, public health, food additives, artificial colors, banned chemicals, ingredient labeling, food labeling, FDA, food and beverage regulation, consumer disclosure, school nutrition, Louisiana Revised Statutes Title 40, Louisiana Revised Statutes Title 17, food manufacturers, food retailers, compliance, effective date delay

Transcript Highlights:

• I would call that medically necessary. I would call that medically necessary.
• All PrEP medications prior to 2025 have an A rating.
• Kenneth Mayer, professor of medicine at Harvard Medical School and Medical Research Director at Fenway
• Maybe we're going to give the medical supply company $7 when it really costs the medical supply company
• So the medical supply company decides...

Keywords: 995, all

Summary: The Joint Committee on Financial Services held a public hearing on a wide range of bills, with testimony first focused on H. 1315/S. 824, which would require insurance coverage for pain management options during IUD insertion. Representative Sabadosa, Planned Parenthood clinicians, and policy advocates said sedation can reduce fear and trauma, improve access to effective contraception, and should be reimbursed so providers can continue offering it. A Tufts OB-GYN resident also testified that pain control should be standard care for intrauterine procedures. No votes were taken during the hearing. The committee then heard extensive testimony on firefighter health bills, especially H. 1230/S. 690 requiring insurance coverage for cancer screenings for firefighters. Professional Fire Fighters of Massachusetts leaders, a Dana-Farber oncologist, and firefighters themselves described occupational exposure to carcinogens and personal stories of late-stage cancer detection, arguing that early screening can save lives and reduce long-term costs. Representative Crichton and Representative Howitt also spoke in support, and Representative Ayers testified for H. 4012, which would require neurological disorder screenings for firefighters. Committee members expressed support and sympathy, but no action was taken. The hearing also covered H. 3946/S. 756 on hearing aid coverage, with testimony from students, adults with hearing loss, disability advocates, and HLAA representatives describing the educational, social, and financial barriers caused by lack of coverage and urging broader insurance mandates. Later, Representative Donahue and Representative Vargas testified for H. 1337 to expand insurance coverage for opioid antagonists and related medications, including naloxone dispensed at discharge. The committee additionally heard testimony on H. 1134 to improve chronic pain care coordination and non-opioid access, and H. 4162 to improve ostomy supply coverage and access to certified ostomy care, with patients and clinicians describing denials, quantity limits, and non-medical switching. The transcript ends while testimony on H. 1315/S. 824 is still ongoing; no votes or formal committee actions are recorded in the excerpt.

Transcript Highlights:

• They're administering the medications, but I order the medications, and so I need to ensure nothing happens
• medication conflicts with an antifungal medication I'm on.
• Pinkard, Chief Medical Examiner, testifying on behalf of the Travis County Medical Examiner for House
• , and he may miss his medication.
• I come from a medical family.

Bills: HB46, HB35, HB4490, HB4454, HB2188, HB3078, HB4743, HB2556, HB46, HB5342, HB4783, HB3785, HB5278, HB1639, HB2581, HB4224, HB4070, HB4099, HB4882, HB3794

Keywords: local government spending cap, expenditure limit, political subdivision, property tax, ad valorem tax, budget cap, taxpayer protection, spending restraint, inflation adjustment, population growth, voter approval, supermajority vote, county budget, municipal budget, school district finance, junior college district, hospital district, special district, attorney general enforcement, local fiscal limits

Transcript Highlights:

• “As a result, critical eye medications for horses and important medications for exotic animals such as
• Pharmacists do more than dispense medications.
• George Sorries, with the California Medical Association.
• Psychiatrists also prescribe antipsychotic medications, and they can also prescribe medications that
• Our patients should have access to 503A medications.

Summary: The joint Assembly and Senate business committees held a sunset review hearing on the California State Board of Pharmacy, with board leadership describing the board’s consumer-protection role and its priorities around access, enforcement, and updating pharmacy law. The board emphasized a proposed shift toward a standard-of-care model for pharmacists, arguing it would reduce rigid protocol requirements and improve access to services such as HIV PrEP/PEP, contraception, and naloxone. Board representatives also discussed pharmacy deserts, possible fee waivers for pharmacies in underserved areas, concerns about payer practices contributing to closures, continuing education audits, and a request to restore more flexibility in licensure decisions and probationary monitoring for applicants with certain criminal histories. A major focus of the hearing was the board’s ongoing compounding regulations, especially the treatment of sterile versus nonsterile compounding and substances such as glutathione and methylcobalamin. The board said the proposal was not a ban on those substances and described the rulemaking as grounded in federal law, USP standards, and public comment, noting the process had gone through multiple modified texts and hearings. Testimony from stakeholders was sharply divided: pharmacists, veterinarians, firefighters, naturopathic doctors, and patient advocates warned the rules were restricting access to compounded medications and harming patients and first responders, while the California Medical Association, psychiatric physicians, and PhRMA raised concerns that the board’s proposals could expand pharmacist authority beyond training, affect physician practice, or create safety risks. Other public comments addressed pharmacy technician ratios, remote processing, flavoring medications, hospital-specific regulation, budget and enforcement transparency, and whether the board should add members with community compounding or pharmacy technician expertise. Committee members also asked about the board’s oversight priorities and the rationale for its standard-of-care proposal. Board staff explained that consumer protection includes education, licensing, policy, and enforcement, with the highest-priority enforcement cases being those posing imminent public harm. After public testimony concluded, the chairs thanked participants and adjourned the sunset review hearing, announcing an immediate transition to the joint informational hearing on the Department of Cannabis Control.